Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (33 total)
-
Autor: Kraft, Colleen S., Aneesh K. Mehta, Jay B. Varkey, G. Marshall Lyon, Sharon Vanairsdale, Sonia Bell, Eileen M. Burd, Mary Elizabeth Sexton, Leslie Anne Cassidy, Patricia Olinger, Kalpana Rengarajan, Vanessa N. Raabe, Emily Davis, Scott Henderson,…
Tema: Personnel Management
Tipo de elemento: Publicación
Fecha de actualización: 2020-04
Descripción: Healthcare personnel (HCP) were recruited to provide serum samples, which were tested for antibodies against Ebola or Lassa virus to evaluate for asymptomatic seroconversion.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Autor: Zhang, Yan, Meng Xiao, Shulan Zhang, Peng Xia, Wei Cao, Wei Jiang, Huan Chen, Xin Ding, Hua Zhao, Hongmin Zhang, Chunyao Wang, Jing Zhao, Xuefeng Sun, Ran Tian, Wei Wu, Dong Wu, Jie Ma, Yu Chen, Dong Zhang, Jing Xie, Xiaowei Yan, Xiang Zhou, Zhengyin…
Tema: Laboratory
Tipo de elemento: Publicación
Fecha de actualización: 2020-04-23
Descripción: Describing a patient with Covid-19 and clinically significant coagulopathy, antiphospholipid antibodies, and multiple infarcts. He was one of three patients with these findings in an intensive care unit designated for patients with Covid-19. -
Autor: McElroy, Anita K., Rama S. Akondy, David R. McLlwain, Han Chen, Zach Bjornson-Hooper, Nilanjan Mukherjee, Aneesh K. Mehta, Garry Nolan, Stuart T. Nichol, and Christina F. Spiropoulou.
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-05-21
Descripción: A complete understanding of human immune responses to Ebola virus infection is limited by the availability of specimens and the requirement for biosafety level 4 (BSL-4) containment. -
Autor: Sridhar V Basavaraju, Monica E Patton, Kacie Grimm, Mohammed Ata Ur Rasheed, Sandra Lester, Lisa Mills, Megan Stumpf, Brandi Freeman, Azaibi Tamin, Jennifer Harcourt, Jarad Schiffer, Vera Semenova, Han Li, Bailey Alston, Muyiwa Ategbole, Shanna…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-11-30
Descripción: SARS-CoV-2, the virus that causes COVID-19 disease, was first identified in Wuhan, China in December 2019, with subsequent worldwide spread. The first U.S. cases were identified in January 2020. -
Autor: Marks, Michael, Pere Millat-Martinez, Dan Ouchi, Chrissy h Roberts, Andrea Alemany, Marc Corbacho-Monné, Maria Ubals, Aurelio Tobias, Cristian Tebé, Ester Ballana, Quique Bassat, Bàrbara Baro, Martí Vall-Mayans, Camila G-Beiras, Nuria Prat, Jordi…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2021-02-02
Descripción: Scarce data are available on what variables affect the risk of transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the development of symptomatic COVID-19, and, particularly, the relationship with viral load. We aimed to… -
Autor: NETEC
Tema: Research
Tipo de elemento: Webinar
Fecha de actualización: 2021-02-12
Descripción: In this webinar, we will define mutation and variant as they relate to SARS-CoV-2, discuss the importance of the current variants and mutations including future predictions surrounding the epidemiology of spread and modeling and describe what is… -
Autor: Thielen, P. M., S. Wohl, T. Mehoke, S. Ramakrishnan, M. Kirsche, O. Falade-Nwulia, N. S. Trovão, A. Ernlund, C. Howser, N. Sadowski, C. P. Morris, M. Hopkins, M. Schwartz, Y. Fan, V. Gniazdowski, J. Lessler, L. Sauer, M. C. Schatz, J. D. Evans, S. C.…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2021-03-22
Descripción: The early COVID-19 pandemic was characterized by rapid global spread. In Maryland and Washington, DC, United States, more than 2500 cases were reported within 3 weeks of the first COVID-19 detection in March 2020. -
Autor: the Oxford COVID-19 Vaccine Trial Group
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2021-03-30
Descripción: A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the efficacy of the adenoviral vector vaccine, ChAdOx1 nCoV-19 (AZD1222), against this variant. -
Autor: NETEC
Tema: Research
Tipo de elemento: Webinar
Fecha de actualización: 2021-05-05
Descripción: Objectives: Define what constitutes a SARS-CoV-2 variant of concern Describe clinical implications of variant of concern cases Identify what lessons US healthcare teams can learn from international experiences with variants of concern Webinar… -
Autor: University of Nebraska Medical Center / Nebraska Medicine
Tema: Training and Exercises
Tipo de elemento: Video
Fecha de actualización: 2021-08-05
Descripción: Dr. Lawler held a news conference on August 5, 2021 to explain the Delta variant of COVID-19.